Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.52−0.09 (-5.30%)
Close on Nov 17, 2026Market cap $24.93MP/E –Yield –
Cellyan Biotechnology operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2026 it was -17.8%, against -11.2% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -17.8% | −6.5 |
| FY2025 | Mar 31, 2025 | -11.2% | +0.5 |
| FY2024 | Mar 31, 2024 | -11.7% | +2.6 |
| FY2023 | Mar 31, 2023 | -14.3% | – |
See a number that looks wrong?